Resmed's Australia shares fall; Macquarie hikes PT

ResMed

03/02/2025 02:50

** Healthcare technology co Resmed's Australia-listed shares
 RMD.AX  fall 2.7% to A$39.105, on track for worst session since
Oct. 29, 2024 - if current losses hold
    ** Stock tracks a sell-off in broader market  .AXJO , which
is down 1.7%  .AX 
    ** Meanwhile, Macquarie hikes PT to A$45.10 from A$41.10,
signalling a 9.7% upside potential
    ** PT hike reflects 1% increase in earnings forecasts for
FY25 and 26, driven by foreign exchange and buyback assumptions
adjustments, among others
    ** Nine of 11 analysts rate the stock "buy" or higher, and
two "hold"; their median PT is A$43.80 – LSEG data
    ** Stock rose 44.5% in 2024

 (Reporting by Nichiket Sunil in Bengaluru)
 ((Nichiket.Sunil@thomsonreuters.com;))